Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 2 |
2012 | 3 |
2019 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment.
Dig Liver Dis. 2011 Nov;43(11):850-5. doi: 10.1016/j.dld.2011.04.002. Epub 2011 May 18.
Dig Liver Dis. 2011.
PMID: 21596633
Review.
Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France.
Clay E, Cristeau O, Chafaie R, Pinta A, Mazaleyrat B, Cottin V.
Clay E, et al. Among authors: pinta a.
J Mark Access Health Policy. 2019 Jun 24;7(1):1626171. doi: 10.1080/20016689.2019.1626171. eCollection 2019.
J Mark Access Health Policy. 2019.
PMID: 31275535
Free PMC article.
Item in Clipboard
Lack of benefit of 3-month intensification with enfuvirtide plus optimized background regimen (OBR) versus OBR alone in patients with multiple therapeutic failures: the INNOVE study.
Morand-Joubert L, Ghosn J, Delaugerre C, Giffo B, Solas C, Samri A, Pinta A, Triglia A, Raffi F; Innove Study Group.
Morand-Joubert L, et al. Among authors: pinta a.
J Med Virol. 2012 Nov;84(11):1710-8. doi: 10.1002/jmv.23388.
J Med Virol. 2012.
PMID: 22997073
Clinical Trial.
Item in Clipboard
Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study.
Zarski JP, Sturm N, Desmorat H, Melin P, Raabe JJ, Bonny C, Sogni P, Pinta A, Rouanet S, Babany G, Cheveau A, Chevallier M.
Zarski JP, et al. Among authors: pinta a.
Liver Int. 2010 Aug;30(7):1049-58. doi: 10.1111/j.1478-3231.2010.02265.x. Epub 2010 May 21.
Liver Int. 2010.
PMID: 20492512
Clinical Trial.
Item in Clipboard
Fibrosis progression under maintenance interferon in hepatitis C is better detected by blood test than liver morphometry.
Calès P, Zarski JP, Chapplain JM, Bertrais S, Sturm N, Michelet C, Babany G, Chaigneau J, Eddine Charaf M; multicentric groups (Fibrosys, ANRS HC 12, Fibrostop).
Calès P, et al.
J Viral Hepat. 2012 Feb;19(2):e143-53. doi: 10.1111/j.1365-2893.2011.01531.x. Epub 2011 Oct 30.
J Viral Hepat. 2012.
PMID: 22239512
Item in Clipboard
Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007).
Bourlière M, Ouzan D, Rosenheim M, Doffoël M, Marcellin P, Pawlotsky JM, Salomon L, Fagnani F, Rouanet S, Pinta A, Vray M.
Bourlière M, et al. Among authors: pinta a.
Antivir Ther. 2012;17(1):101-10. doi: 10.3851/IMP1935.
Antivir Ther. 2012.
PMID: 22267474
Item in Clipboard
Cite
Cite